Lactulose induced maculo-papular eruption with positive rechallenge: Unusual reaction to this medication - 21/05/25
Doi : 10.1016/j.therap.2024.12.004
Imen Bouaziz a, ⁎ 
, Rim Atheymen a, Khadija Sellami b, Rym Sahnoun a, Kamilia Ksouda a, Emna Bahloul b, Hanen Affes a, Serria Hammami a, Hamida Turki b, Khaled Zghal a
, Rim Atheymen a, Khadija Sellami b, Rym Sahnoun a, Kamilia Ksouda a, Emna Bahloul b, Hanen Affes a, Serria Hammami a, Hamida Turki b, Khaled Zghal a a Regional Centre of Pharmacovigilance of Sfax, Faculty of Medicine of Sfax, University of Sfax, 3029 Sfax, Tunisia
b Department of Dermatology, Hedi Chaker University Hospital, 3029 Sfax, Tunisia
⁎Corresponding author. Centre régional de pharmacovigilance de Sfax, laboratoire de pharmacologie, faculté de médecine de Sfax, avenue Majida Boulila, 3029 Sfax, Tunisia.Centre régional de pharmacovigilance de Sfax, laboratoire de pharmacologie, faculté de médecine de Sfaxavenue Majida BoulilaSfax3029Tunisia
Keywords : Lactulose, Maculopapular eruption, Positive rechallenge, Patch test, Imputability
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| ☆ | This case was notified to regional center of pharmacovigilance (RCPV) of Sfax (Tunisia) and recorded on 26 October 2022 under the number 542/2022. |
© 2024
Société française de pharmacologie et de thérapeutique. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 80 - N° 3
P. 354-356 - maggio 2025 Ritorno al numero
Articolo precedente
- Polyintoxication with cenobamate, perampanel, and carbamazepine: A complex case report
- Alexandre Destere, Alexandre O. Gérard, Diane Merino, Elliot Ewig, Fanny Rocher, Nouha Ben Othmann, Benjamin Hennart, Jean Dellamonica, Hervé Hyvernat, Milou-Daniel Drici
- Adalimumab-induced myoclonus: A potential adverse drug reaction?
- Yasmine Salem Mahjoubi, Israa Dahmani, Fatma Zgolli, Widd Kaabi, Sarrah Kastalli, Imen Aouintin, Sihem El Aidli
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?